Pulliam Christopher L, Stanslaski Scott R, Denison Timothy J
Medtronic RTG Implantables, Minneapolis, MN, United States.
Medtronic RTG Implantables, Minneapolis, MN, United States; MRC Brain Network Dynamics Unit, University of Oxford, Oxford, United Kingdom.
Handb Clin Neurol. 2020;168:341-352. doi: 10.1016/B978-0-444-63934-9.00025-1.
Neuromodulation therapies offer a unique opportunity for translating brain-computer interface (BCI) technologies into a clinical setting. Several diseases such as Parkinson's disease are effectively treated by invasive device stimulation therapies, and the addition of sensing and algorithm technology is an obvious evolutionary expansion of capabilities. In addition, this infrastructure might enable a roadmap of novel BCI technologies. While the initial applications are focused on epilepsy and movement disorders, the technology is potentially transferable to a broader base of disorders, including stroke and rehabilitation. The ultimate potential of BCI technology will be determined by forthcoming chronic evaluation in multiple neurologic disorders.
神经调节疗法为将脑机接口（BCI）技术转化为临床应用提供了独特的契机。诸如帕金森病等多种疾病可通过侵入性设备刺激疗法得到有效治疗，而增加传感和算法技术显然是能力的进一步发展。此外，这种基础设施可能会促成新型脑机接口技术的发展路径。虽然最初的应用集中在癫痫和运动障碍方面，但该技术有可能推广到更广泛的疾病领域，包括中风和康复治疗。脑机接口技术的最终潜力将取决于即将在多种神经系统疾病中进行的长期评估。
